Breast Cancer, Diabetes Mellitus and Glucagon-Like Peptide-1 Receptor Toward Exploring Their Possible Associations
Naoko Hashimoto Takigami et al, 2021, Breast Cancer Research and Treatment CrossRef
Glucagon-like peptide 1 in health and disease
Andreas Andersen et al, 2018, Nature Reviews Endocrinology CrossRef
CD26/DPP-4: Type 2 Diabetes Drug Target with Potential Influence on Cancer Biology
Emi Kawakita et al, 2021, Cancers CrossRef
GLP-1 Receptor Agonists and the Risk of Thyroid Cancer
Julien Bezin et al, 2023, Diabetes Care CrossRef
Cancer related safety with SGLT2-i and GLP1-RAs: Should we worry?
M. Gallo et al, 2023, Diabetes Research and Clinical Practice CrossRef
Application of glucagon-like peptide-1 receptor antagonists in fibrotic diseases
Fuxun Yang et al, 2022, Biomedicine & Pharmacotherapy CrossRef
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging
Andrew Smith et al, 2019, Journal of Proteomics CrossRef
Challenges in the management of people with diabetes and cancer
T. A. Chowdhury et al, 2019, Diabetic Medicine CrossRef
Diagnostic significance of apical membranous and cytoplasmic dot-like CD26 expression in encapsulated follicular variant of papillary thyroid carcinoma: a useful marker for capsular invasion
Shoji Takagi et al, 2020, Endocrine Journal CrossRef
Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation
Brent A McLean et al, 2021, Endocrine Reviews CrossRef
Protein overexpression of toll‑like receptor 4 and myeloid differentiation factor 88 in oral squamous cell carcinoma and clinical significance
Lili Li et al, 2021, Oncology Letters CrossRef
Cancer biology in diabetes update: Focusing on antidiabetic drugs
Emi Kawakita et al, 2024, Journal of Diabetes Investigation CrossRef
The role of incretins and incretin-based drugs in autoimmune diseases
Shabnam Radbakhsh et al, 2021, International Immunopharmacology CrossRef